ストックスクリーナーアプリを入手
1.26
3.08%
-0.04
Biomea Fusion Inc (BMEA) 最新ニュース
Does Biomea Fusion Inc stock benefit from AI growth2025 Momentum Check & Consistent Return Strategy Ideas - baoquankhu1.vn
Market Catalysts: Is Biomea Fusion Inc part of any major indexJuly 2025 Rallies & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Biomea Fusion, Inc.'s (NASDAQ:BMEA) largest shareholders are retail investors with 55% ownership, institutions own 38% - Yahoo Finance
Levels Update: Does Biomea Fusion Inc offer margin of safetyQuarterly Performance Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Rodman & Renshaw Initiates Biomea Fusion (BMEA) at Buy with $8 Price Target - Insider Monkey
Biomea Fusion Spotlights Diabetes, Obesity Pipeline at JPMorgan Conference, Sets 2026 Milestones - MarketBeat
BMEA: Durable A1C reduction and advancing weight loss studies highlight strong clinical momentum - TradingView
Biomea Fusion Highlights Diabetes Pipeline at JPM Conference - TipRanks
Biomea Fusion, Inc. Updates on Icovamenib Clinical Progress - TradingView
Rodman & Renshaw Initiates Coverage on Biomea Fusion (NASDAQ:BMEA) - MarketBeat
Rodman & Renshaw initiates Biomea Fusion stock with Buy rating By Investing.com - Investing.com Nigeria
Rodman & Renshaw initiates Biomea Fusion stock with Buy rating - Investing.com
BMEA: Today's Analyst Rating and Price Target Update | BMEA Stoc - GuruFocus
Biomea Fusion (NASDAQ:BMEA) Given Buy Rating at D. Boral Capital - MarketBeat
Published on: 2026-01-13 19:04:12 - Bộ Nội Vụ
Biomea Fusion outlines 2026 diabetes and obesity drug development plans By Investing.com - Investing.com Nigeria
Biomea Fusion outlines 2026 diabetes and obesity drug development plans - Investing.com
Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones - manilatimes.net
Experimental pills for diabetes and obesity line up key 2026 tests - Stock Titan
Biomea Fusion launches public offering of stock and warrants; shares down 23% - MSN
Is Biomea Fusion Inc. stock near bottom after decline2025 Market Outlook & AI Driven Stock Reports - ulpravda.ru
Stop Loss: Is Biomea Fusion Inc. stock near bottom after declineDollar Strength & Advanced Swing Trade Entry Alerts - Улправда
Will Biomea Fusion Inc. stock return to pre crisis levels2026 world cup usa national team round of 16 key players build up play expert forecast preview - ulpravda.ru
Biomea Fusion looks to major milestones in 2026 - Traders Union
Biomea Fusion downgraded to Underweight from Neutral at JPMorgan - MSN
Biomea Fusion Inc. (BMEA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Biomea Fusion explores challenges of insulin therapy - Traders Union
Can Biomea Fusion Inc. stock outperform in 2025 bull marketCEO Change & Detailed Earnings Play Strategies - Улправда
Published on: 2025-12-20 18:19:39 - Улправда
How interest rate cuts could boost Biomea Fusion Inc. stockWeekly Stock Recap & Daily Momentum Trading Reports - Улправда
Published on: 2025-12-20 15:52:57 - Улправда
Will Biomea Fusion Inc. stock split attract more investors2025 Technical Overview & Technical Entry and Exit Alerts - DonanımHaber
Published on: 2025-12-19 02:18:12 - Улправда
Aug Closing: Will Biomea Fusion Inc. stock outperform growth indexesJuly 2025 Action & Risk Controlled Swing Alerts - Улправда
Gap Down: Can Biomea Fusion Inc. stock outperform in 2025 bull market - Улправда
Biomea Fusion, Inc.(NasdaqGS: BMEA) dropped from NASDAQ Biotechnology Index - marketscreener.com
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Biomea Fusion presents COVALENT-111 study results at WCIRDC - MSN
Insider Buying: Biomea Fusion (NASDAQ:BMEA) Insider Acquires 30,000 Shares of Stock - MarketBeat
Biomea Fusion Director Rainer M Erdtmann Acquires 30,000 Shares - TradingView — Track All Markets
[Form 4] Biomea Fusion, Inc. Insider Trading Activity - Stock Titan
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Biomea F - GuruFocus
Interim CEO & Director of Biomea Fusion Michael J. Hitchcock Buys 667% More Shares - simplywall.st
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025 - The Manila Times
Biomea Fusion Highlights the Future of Menin Inhibitors and Icovamenib in Interview with Dr. Ralph DeFronzo at WCIRDC 2025 - Quiver Quantitative
1.73%
3.86%
大文字化:
|
ボリューム (24 時間):